Plain-English translation of NCT06486454 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is evaluating a device called the HistoSonics Edison System, which uses focused ultrasound waves to destroy liver tumors without traditional surgery. Researchers are collecting real-world data on how well the treatment works and how safe it is across different medical centers and patient types. The study will follow patients for up to 5 years after treatment to monitor their recovery and long-term outcomes.
While this ultrasound-based treatment is promising for patients who have liver cancer or tumors, doctors need more information about how it performs when used by different physicians in real clinical practice. This study aims to gather that real-world data to better understand when and how the treatment works best.
You likely qualify if…
You likely don't qualify if…
You will receive the ultrasound-based treatment from your doctor, and imaging will be done within 36 hours afterward to check if the tumor was successfully treated. After that, you'll continue regular follow-up care with your medical team over the next 5 years—this includes standard imaging, office visits, and check-ins about any side effects. The study simply tracks how you're doing as part of normal clinical care; you won't need extra or experimental procedures beyond the initial treatment.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
United States